RxDoctor Payments DataLook up a doctor →

Hoadley Harris, MD

Family Medicine · Fargo, NDNPI 1811991607

Payments from drug & device makers

$829,679in general payments, 2019–2025

Across 545 payments — averaging $1522.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$277K
  • Sanofi Pasteur Inc.$243K
  • AstraZeneca$201K
  • Janssen Research & Development, LLC$90K
  • Alnylam Pharmaceuticals Inc.$9K
  • Astrazeneca UK Limited$5K
  • plus $5K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)84$277,061
Sanofi Pasteur Inc.14$242,979
AstraZeneca52$200,728
Janssen Research & Development, LLC53$89,807
Alnylam Pharmaceuticals Inc.3$8,616
Astrazeneca UK Limited4$5,262
Merck44$692
Lilly USA, LLC44$680
Sanofi-aventis U.S. LLC33$379
Novo Nordisk24$310
Novartis13$254
Boehringer Ingelheim15$247
Takeda Pharmaceuticals U.S.A., Inc.25$213
Grifols USA, LLC10$167
Esperion Therapeutics, Inc.9$147
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$145
Medtronic(2 entities)2$144
Boston Scientific3$141
Amarin Pharma, Inc.7$130
Mylan Specialty L.p.9$127
Antares Pharma, Inc.8$112
Pfizer7$108
Nestle Healthcare Nutrition Inc.6$97
Lundbeck LLC6$88
GSK5$77
Bayer5$76
Ultragenyx Pharmaceutical Inc.4$68
Phathom Pharmaceuticals, Inc.4$55
Johnson & Johnson3$54
Biohaven Pharmaceuticals, Inc.3$51
Amgen3$51
Kowa Pharmaceuticals America, Inc.4$51
Lexicon Pharmaceuticals, Inc.3$47
Medicure Pharma Inc.1$44
Biohaven Pharmaceutical Holding Company Ltd.3$40
Myriad Women's Health, Inc.1$39
Actelion Pharmaceuticals US, Inc.2$37
Radius Health, Inc.3$36
Alkermes, Inc.2$33
Philips North America LLC1$30
Abiomed1$21
Axsome Therapeutics, Inc.1$21
E.r. Squibb & Sons, L.L.C.1$21
Aegerion Pharmaceuticals, Inc.1$18
Eisai Inc.1$17
Acadia Pharmaceuticals Inc1$17
Aimmune Therapeutics, Inc.1$17
Biogen1$16
Idorsia Pharmaceuticals US Inc1$16
Otsuka America Pharmaceutical, Inc.1$16
Viatris Specialty LLC1$15
Neurocrine Biosciences, Inc.1$13
Acorda Therapeutics, Inc1$13
Pacira Therapeutics, Inc.1$13
Exeltis, USA Inc.1$12
Roche Diagnostics Corporation1$12

How this compares

$829,679 in reported general payments places this provider in the 95th percentile of 337 family medicine providers in North Dakota.

See all family medicine providers in North Dakota →

Medicare billing

Part B allowed, 2024
$107,731
Medicare patients
257
Services billed
10,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Fargo

See the full list for North Dakota →

Where these figures come from

Is this you, or does something look wrong? →